You searched for "Nasal"
Funding your otolaryngology / audiology idea by partnering with the US Department of Defense
The United States Department of Defense (DoD) has been an effective partner in many of our current medical technology advancements, from the surgical robot, to improved clotting wound dressings, to better blood products. For the otolaryngology and audiology entrepreneur looking...Migration adventures
One of the most inspiring stories in this issue comes from our very own Shahed Quraishi, OBE. His first mentor in the UK, Pat Bradley, spoke with him about his fascinating journey. Professor M Shahed Quraishi, OBE. Shahed, by way...Cochlear implantation in the developing world: perspectives from the Indian subcontinent
Cochlear implants are an expensive technology, yet profound hearing loss is far from a developed-world phenomenon. On the contrary, incidences of both congenital and acquired hearing losses are high in the developing world. This article explains how an initiative in...
British Skull Base Society Clinical Consensus Document on Management of Head and Neck Paragangliomas (HNPGLs)
All forms of HNPGLs should be managed by a multidisciplinary team (MDT) of core members from skull base otolaryngology, head and neck surgery, clinical genetics, oncology, endocrinology, vascular surgery, radiology and pathology. Extended members include neurosurgery, endocrine surgery, nuclear medicine,...
Coupler microvascular anastomoses: how good?
This paper is written by a group of reconstructive surgeons and a school of computing. The study used computational fluid dynamics to model blood flow through idealised sutured and coupled vessels, to investigate if differing anastomotic techniques affect intravascular blood...COOL therapy for cisplatin-induced hearing loss
Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...
